文献速递头颈部肿瘤放疗

舌偏移与舌压口腔支架对口咽癌幸存者长期放疗相关症状的影响

The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors.
PubMed 文献 · Clin Transl Radiat Oncol · 2020-06-09

本研究基于前瞻性观察队列,纳入462例无病口咽癌幸存者,评估调强放疗期间使用口腔支架与长期患者报告症状的关联。中位随访68个月,舌偏移支架用于17%、舌压支架用于46%、未用支架37%。单侧颈部放疗者中舌偏移支架与中度/重度味觉损害和食欲缺乏比例降低相关;双侧颈部放疗者中舌压支架与中度/重度吞咽/咀嚼困难比例降低相关。

要点

  • 单侧颈部放疗者用舌偏移支架,中度/重度味觉损害2% vs 15%(p=0.047)。
  • 单侧颈部放疗者用舌偏移支架,中度/重度食欲缺乏0% vs 9%(p=0.019)。
  • 双侧颈部放疗者用舌压支架,中度/重度吞咽/咀嚼困难21% vs 31%(p=0.013)。

核心结论

  • 口咽癌调强放疗期间按疾病部位选择性使用口腔支架,与幸存者长期患者报告症状减少相关。

研究设计与样本

  • 前瞻性观察研究,纳入462例无病头颈癌幸存者中的口咽癌患者,中位随访68个月。

主要发现

  • 舌偏移支架使用17%,舌压支架使用46%,未用支架37%;54%为扁桃体原发,46%为舌根原发。
  • 双侧颈部放疗者中,舌压支架组中度/重度吞咽/咀嚼困难21% vs 未用支架31%(p=0.013)。

关键数值与推荐

  • 症状采用MDASI-HN评估,评分≥5(11点Likert量表,0-10)定义为中度/重度。
  • 高危临床靶区中位处方剂量66.0 Gy。

临床怎么用

  • 口咽癌调强放疗时可依据疾病部位和照射范围选择性使用口腔支架,以减轻长期味觉、食欲及吞咽/咀嚼相关症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether the use of oral stents during intensity modulated radiation therapy (IMRT) for oropharyngeal cancer (OPC) is associated with long-term patient reported symptoms. MATERIALS AND METHODS: Data was obtained from a prospective observational study of disease-free head and neck cancer survivors. Radiation-associated patient reported symptoms were assessed using the MD Anderson Symptom Inventory Head and Neck module (MDASI-HN). Scores of ≥5 (11-point Likert scale, 0-10) were considered moderate/severe. Stratification was performed regarding IMRT volume (uni- versus bilateral neck) and stent utilization, with non-parametric analyses between groups. RESULTS: 462 OPC survivors formed the cohort (54% tonsil, 46% base of tongue primaries). A tongue-deviating stent was used in 17%, tongue-depressing stent in 46%, and no stent in 37%. Median prescribed dose to the high dose clinical target volume was 66.0 Gy. Median follow-up from RT to MDASI-HN assessment was 68 months. Twenty percent had received unilateral neck RT (all had tonsil primaries), in whom a significant improvement in the proportion of patients with moderate/severe taste impairment (2% vs. 15%, p = 0.047) and lack of appetite (0% vs. 9%, p = 0.019) was associated with the use of tongue-deviating stents compared to no oral stent. In those who had received bilateral neck RT, a significant improvement in the proportion of patients with moderate/severe difficulty swallowing/chewing was associated with use of a tongue-depressing stent (21% vs. 31% without oral stent, p = 0.013). CONCLUSION: Disease-site specific select use of oral stents during IMRT was associated with reduced long-term patient reported symptoms in OPC survivors.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Stieb S, Perez-Martinez I, Mohamed ASR, et al. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors. Clin Transl Radiat Oncol. 2020. PMID: 32642562. doi:10.1016/j.ctro.2020.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。